Profiling of differentially expressed genes in human Gastric carcinoma by cDNA expression array

Table 1 Genes differentially expressed between HCC and adjacent noamal liver tissues generated by atlasImage software (Version 1.01a)

Gene	Ratio	Difference	Protein/gene
B2f		-42675	TRAF6
E2h	0.171	-31204	T-plasminogen activator (T-PA)
B3h	0.444	-31180	caspase-8 precursor; MACH; FLICE; (CAP4) (CASP8)
D1b	0.334	-30676	byglycan
B3i	0.445	-30287	caspase-9 precursor; ICE-LAP6; apoptotic protease MCH-6
B2g	0.493	-28449	TRAF-interacting protein (TRIP)
B3g		-27610	caspase-8 precursor; MCH-5 isoform alpha
E4j	0.346	-27534	CDC42 GTPase-activating protein
C7m	0.336	-27032	retinoid X receptor beta (RXR-beta)
B1k	0.438	-26170	serine/threonine protein kinase NIK;
B3j	0.486	-25940	ICE-like apoptotic protease 4 precursor; caspase-10
B3f		-25206	caspase-7 precursor; apoptotic protease MCH-3; LICE2
F2g	0.428	-23730	endothelin ET2
D2a	0.176	-22099	collagen type VIII alpha-1
D7f	0.47	-21445	PLGF1 & 2 precursor (placenta growth factor)
C7l	0.593	-21145	retinoic acid receptor gamma
A4j	0.326	-20847	extracellular signal-regulated kinase 6 (ERK6) (ERK5)
E5b	0.299	-20388	rho GDP-dissociation inhibitor 1
E2f	0.638	-20244	extracellular matrix metalloproteinase inducer emmprin
D4j	0.624	-20147	integrin beta7
D2n	0.646	-17013	TENASCIN-R
F4l	0.626	-16150	interleukin-6 (IL-6) precursor; BSF-2; interferon beta-2;
B5l	0.633	-16122	proto-oncogene rhoA multidrug resistance protein;
B7j	0.639	-15630	tyrosine-protein kinase ABL2; tyrosine kinase ARG (ABLL)
E7l	0.721	-15615	ephrin type-B receptor 2 precursor; tyrosine-protein eph-3
E1f	0.318	-15559	MMP-9; gelatinase B
B2i	0.245	-15356	CD40 receptor associated factor 1 (CRAF1)
D5g	0.569	-15106	ezrin (cytovillin 2)
E7k		-14688	ephrin type-B receptor 1 precursor; NET
E1j		-14540	MMP-13; collagenase-3
A2f	0.403	-14368	serine/threonine protein kinase PITALRE
D5m	0.38	-14156	tumor suppressor DCC colorectal
E1e	0.3	-13906	MMP-8; collagenase-2
D2e	0.295	-13706	collagen type XVIII alpha
D2m	0.624	-12991	tenascin-C
F3j	0.77	-12411	transcription factor ETR103; early growth response protein 1
C2j	0.648	-12053	Rad
F5k	0.68	-11371	leukocyte interferon-gamma (IFN-gamma)
D5k	0.643	-11064	ninjurin-1
C7k	0.356	-11056	retinoic acid receptor epsilon; retinoic acid receptor beta-2
C1b	0.392	-10834	ataxia telangiectasia (ATM)
D4k	0.799	-10645	integrin beta8
D1c		-10630	CD34
D3e	0.798	-10529	vitronectin precursor; serum spreading factor;
B4c	0.347	-10506	WSL-LR +WSL-S1+WSL-S2+TRAMP (Apo-3)
D6c	0.264	-10460	semaphorin E
E2n	0.483	-9167	low-density lipoprotein receptor-related protein 1 precursor
E5m	0.351	-8076	truncated-cadherin; H-cadherin; heart-cadherin
A4n	0.363	-7958	stress-activated protein kinase JNK3; JNK3;
A5i	0.282	-7204	E2F-3
E6f	0.287	-7197	neuroendocrine-dlg (NE-dlg);
A1e	0.343	-7043	cell division protein kinase 5; kinase PSSALRE
E4h	0.419	-6025	rhoHP1
D6h	0.451	-4647	LAR
A7n	0.466	-4426	desmin
E4e	2.185	4701	RAS-related C3 botulinum toxin substrate 1 (P21-RAC2)
D5f	1.447	10249	CD9
B7g	2.841	11419	SKY (DTK) (TYRO3) (RSE)
A7d	2.705	13394	type II cytoskeletal 11 keratin; cytokeratin 1 (K1; CK 1)
D6f	2.772	14015	semaphorin-1
D6e	3.182	15879	semaphorin V
E1b	3.079	15956	MMP-2; gelatinase A
E1m	2	17032	MMP-16 (MT3-MMP)